Table 5.
Correlation between baseline clinical condition and macrophage type in MC subgroups
‘Back pain+’ is defined as NRS≥4; ‘Leg pain+’ is defined as NRS≥4; ‘ODI +’ is defined as ODI≥24; N = available/total; Fisher's exact test was used for comparisons between groups; ∗ P-value <0.05
| Back pain+ N (%) |
Leg pain+ N (%) |
ODI+ N (%) |
|
|---|---|---|---|
| No MC | |||
| M1 dominant (N = 39/49) | 24 (62 %) | 37 (93 %) | 35 (90 %) |
| M1 = M2 (N = 12/16) | 9 (75 %) | 12 (100 %) | 12 (100 %) |
| M2 dominant (N = 10/10) | 6 (60 %) | 10 (100 %) | 9 (90 %) |
| No MF (N = 22/29) | 11 (50 %) | 15 (65 %) | 17 (77 %) |
| p-value | 0.590 | 0.006∗ | 0.275 |
| With MC I | |||
| M1 dominant (N = 9/12) | 7 (78 %) | 8 (89 %) | 7 (78 %) |
| M1 = M2 (N = 2/2) | 2 (100 %) | 1 (50 %) | 2 (100 %) |
| M2 dominant (N = 1/1) | 1 (100 %) | 1 (100 %) | 1 (100 %) |
| No MF (N = 1/1) | 1 (100 %) | 1 (100 %) | 1 (100 %) |
| p-value | 1.000 | 0.538 | 1.000 |
| With MC II | |||
| M1 dominant (N = 25/28) | 20 (80 %) | 23 (88 %) | 24 (96 %) |
| M1 = M2 (N = 9/10) | 7 (78 %) | 9 (100 %) | 8 (89 %) |
| M2 dominant (N = 5/6) | 2 (40 %) | 5 (100 %) | 5 (100 %) |
| No MF (N = 19/25) | 5 (26 %) | 19 (100 %) | 18 (95 %) |
| p-value | 0.001∗ | 0.447 | 0.815 |